ESPL1 and hepatocellular carcinoma: Additionally, Hu et al. (2020) discovered that a fusion gene involving human ESPL1 integrated with HBV S may serve as a potential biomarker for the early diagnosis of hepatocellular carcinoma (HCC) in patients infected with HBV (Hu et al., 2020).